ARS PHARMACEUTICA : Impact Factor & More
eISSN: 2340-9894pISSN: 0004-2927
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
ARS PHARMACEUTICA Journal Specifications
| Overview | |
| Publisher | UNIV GRANADA, EDITORIAL |
| Language | English,Spanish |
| Frequency | Quarterly |
| Publication Time | 10 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English,Spanish |
| Society/Institute/Sponsor | Universidad de Granada |
| Frequency | Quarterly |
| Publication Start Year | 1960 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Publication Time | 10 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo,Dulcinea |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in ARS PHARMACEUTICA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ARS PHARMACEUTICA
Beers, STOPP/START y PRISCUS: análisis crítico de su evolución y aplicabilidad en la prescripción geriátrica
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Enhancement of Solubility Profiles of Azelnidipine: Drug-Likeliness, Pastille Formulation, In-Vitro Drug Release Kinetics, and Evaluation Studies
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Development and Characterization of Rapid Dissolving films of Fluoxetine HCl by 32 Factorial Design Approach
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Enhanced Solubility and Dissolution of Selexipag via β-Cyclodextrin Inclusion Complexes: Formulation and Evaluation
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Biosimilar eculizumab and meningococcal meningitis: the importance of strengthening health education
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Características clínicas y sociodemográficas de pacientes con alergia a betalactámicos: Revisión estructurada
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Beers, STOPP/START y PRISCUS: análisis crítico de su evolución y aplicabilidad en la prescripción geriátrica
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Enhancement of Solubility Profiles of Azelnidipine: Drug-Likeliness, Pastille Formulation, In-Vitro Drug Release Kinetics, and Evaluation Studies
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Development and Characterization of Rapid Dissolving films of Fluoxetine HCl by 32 Factorial Design Approach
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Enhanced Solubility and Dissolution of Selexipag via β-Cyclodextrin Inclusion Complexes: Formulation and Evaluation
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Biosimilar eculizumab and meningococcal meningitis: the importance of strengthening health education
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
Características clínicas y sociodemográficas de pacientes con alergia a betalactámicos: Revisión estructurada
- 20 Dec 2025
- Ars Pharmaceutica (Internet)
FAQs on ARS PHARMACEUTICA
How long has ARS PHARMACEUTICA been actively publishing? 
What is the publishing frequency of ARS PHARMACEUTICA?
How many articles did ARS PHARMACEUTICA publish last year?
What is the eISSN & pISSN for ARS PHARMACEUTICA?
Who is the publisher of ARS PHARMACEUTICA?
